HARRIGAN EDMUND

CIK 00011779175 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001177917

Recent Transactions

50 trades

Award
INCYTE CORP$INCY
Common Stock
2025-12-31$98.77/sh+245→ 20,853 total
Award
INCYTE CORP$INCY
Common Stock
2025-09-30$84.81/sh+289→ 20,608 total
Award
INCYTE CORP$INCY
Common Stock
2025-06-30$68.10/sh+367→ 20,319 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2025-06-10+9,216→ 9,216 total
Award
INCYTE CORP$INCY
Common Stock
2025-06-10+2,518→ 19,952 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-29+9,387→ 35,041 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29−9,387→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29+8,107→ 8,107 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2025-05-29+13,793→ 13,793 total
Award
INCYTE CORP$INCY
Common Stock
2025-03-31$60.55/sh+363→ 17,434 total
Award
INCYTE CORP$INCY
Common Stock
2024-12-31$69.07/sh+339→ 17,071 total
Award
INCYTE CORP$INCY
Common Stock
2024-09-30$66.10/sh+378→ 16,732 total
Award
INCYTE CORP$INCY
Common Stock
2024-06-28$60.62/sh+409→ 16,354 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2024-06-12+12,517→ 12,517 total
Award
INCYTE CORP$INCY
Common Stock
2024-06-12+2,830→ 15,945 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29−6,652→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-29+6,652→ 25,654 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2024-05-29+15,959→ 15,959 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29+9,387→ 9,387 total
Award
INCYTE CORP$INCY
Common Stock
2024-03-28$56.97/sh+413→ 13,115 total
Award
INCYTE CORP$INCY
Common Stock
2023-12-29$62.79/sh+423→ 12,702 total
Award
INCYTE CORP$INCY
Common Stock
2023-09-29$57.77/sh+389→ 12,279 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-30$62.25/sh+390→ 11,890 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2023-06-14+11,294→ 11,294 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-14+2,505→ 11,500 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2023-06-01+11,045→ 11,045 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01+6,652→ 6,652 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01−8,552→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-06-01+8,552→ 19,002 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2023-05-19+3,750→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2023-05-19+3,750→ 9,750 total
Award
INCYTE CORP$INCY
Common Stock
2023-03-31$72.27/sh+326→ 8,995 total
Award
INCYTE CORP$INCY
Common Stock
2022-12-30$80.32/sh+302→ 8,669 total
Award
INCYTE CORP$INCY
Common Stock
2022-10-19$69.59/sh+165→ 8,367 total
Award
INCYTE CORP$INCY
Common Stock
2022-09-30$66.64/sh+250→ 8,202 total
Award
INCYTE CORP$INCY
Common Stock
2022-06-30$75.97/sh+236→ 7,952 total
Award
INCYTE CORP$INCY
Common Stock
2022-06-15+2,144→ 7,716 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2022-06-15+9,124→ 9,124 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2022-06-07+6,391→ 10,450 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2022-06-07+14,368→ 14,368 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-06-07+8,552→ 8,552 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-06-07−6,391→ 0 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+3,750→ 3,750 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 total
Award
INCYTE CORP$INCY
Common Stock
2022-03-31$79.42/sh+240→ 5,572 total
Award
INCYTE CORP$INCY
Common Stock
2021-12-31$73.40/sh+253→ 5,332 total
Award
INCYTE CORP$INCY
Common Stock
2021-09-30$68.78/sh+237→ 5,079 total
Award
INCYTE CORP$INCY
Common Stock
2021-06-30$84.13/sh+208→ 4,842 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2021-06-22+6,391→ 6,391 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2021-06-22+11,637→ 11,637 total

Companies

Recent Filings

Address

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE, 19803

View on SEC.gov